Remyelination as Neuroprotection

Multiple Sclerosis As A Neuronal Disease

Volumn , Issue , 2005, Pages 389-419

  Howe, Charles L ^a   Rodriguez, Moses ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33747163119     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012738761-1/50028-6     Document Type: Chapter

References (196)

1. Z. Ahmed, A.I. Doward, G. Pryce, D.L. Taylor, J.M. Pocock, J.P. Leonard, D. Baker and M.L. Cuzner (2002) A role for caspase-1 and -3 in the pathology of experimentals allergic encephalomyelitis: Inflammation versus degeneration. Am. J. Pathol. 161 1577-1586.
2. A. Altintas, Z. Cai, L.R. Pease and M. Rodriguez (1993) Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler's virus. J. Immunol. 151 2803-2812.
3. H.A. Arnett, J. Mason, M. Marino, K. Suzuki, G.K. Matsushima and J.P. Ting (2001) TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 4 1116-1122.
4. H.A. Arnett, Y. Wang, G.K. Matsushima, K. Suzuki and J.P. Ting (2003) Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J. Neurosci 23 9824-9832.
5. K. Asakura, D.J. Miller, K. Murray, R. Bansal, S.E. Pfeiffer and M. Rodriguez (1996) Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes. J. Neurosci. Res. 43 273-281.
6. K. Asakura, D.J. Miller, L.R. Pease and M. Rodriguez (1998) Targeting of IgM kappa antibodies to oligodendrocytes promotes CNS remyelination. J. Neurosci. 18 7700-7708.
7. H. Babbe, A. Roers, A. Waisman, H. Lassmann, N. Goebels, R. Hohlfeld, M. Friese, R. Schroder, M. Deckert, S. Schmidt, R. Ravid and K. Rajewsky (2000) Clonal expansions of CD8(+)T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192 393-404.
8. W. Baron, L. Decker, H. Colognato and C. ffrench-Constant (2003) Regulation of integrin growth factor interactions in oligodendrocytes by lipid raft microdomains. Curr. Biol. 13 151-155.
9. M.D. Bass and M.J. Humphries (2002) Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling. Biochem. J. 368 1-15.
10. W.S. Begolka, L.M. Haynes, J.K. Olson, J. Padilla, K.L. Neville, M. Dal Canto, J. Palma, B.S. Kim and S.D. Miller (2001) CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology. J. Neurovirol. 7 409-420.
11. M. Bernfield, M. Gotte, P.W. Park, O. Reizes, M.L. Fitzgerald, J. Lincecum and M. Zako (1999) Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68 729-777.
12. A.J. Bieber, A. Warrington, L.R. Pease and M. Rodriguez (2001) Humoral autoimmunity as a mediator of CNS repair. Trends Neurosci. 24 S39-S44.
13. A. Bitsch, J. Schuchardt, S. Bunkowski, T. Kuhlmann and W. Bruck (2000) Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123 1174-1183.
14. C. Bjartmar and B.D. Trapp (2003) Axonal degeneration and progressive neurologic disability in multiple sclerosis. Neurotox. Res. 5 157-164.
15. C. Bjartmar, J.R. Wujek and B.D. Trapp (2003) Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J. Neurol. Sci. 206 165-171.
16. G.M. Bokoch (2003) Biology of the p21-Activated Kinases. Annu. Rev. Biochem. 72 743-781.
17. B. Bonetti and C.S. Raine (1997) Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42 74-84.
18. S. Bonini, G. Rasi, M.L. Bracci-Laudiero, A. Procoli and L. Aloe (2003) Nerve growth factor: neurotrophin or cytokine? Int. Arch. Allergy Immunol. 131 80-84.
19. N.D. Borson, C. Paul, X. Lin, W.K. Nevala, M.A. Strausbauch, M. Rodriguez and P.J. Wettstein (1997) Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J. Virol. 71 5244-5250.
20. J.P. Bouvet and G. Dighiero (1998) From natural polyreactive autoantibodies to a la carte monoreactive antibodies to infectious agents: Is it a small world after all? Infect. Immunol. 66 1-4.
21. M. Brahic (2002) Theiler's virus infection of the mouse, or of the importance of studying animal models. Virology 301 1-5.
22. M. Brahic, W.G. Stroop and J.R. Baringer (1981) Theiler's virus persists in glial cells during demyelinating disease. Cell 26 123-128.
23. B.S. Bregman, E. Kunkel-Bagden, L. Schnell, H.N. Dai, D. Gao and M.E. Schwab (1995) Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 378 498-501.
24. K.A. Browne, E. Blink, V.R. Sutton, C.J. Froelich, D.A. Jans and J.A. Trapani (1999) Cytosolic delivery of granzyme B by bacterial toxins: evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perforin. Mol. Cell Biol. 19 8604-8615.
25. W. Bruck, A. Bitsch, H. Kolenda, Y. Bruck, M. Stiefel and H. Lassmann (1997) Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology. Ann. Neurol. 42 783-793.
26. H. Butzkueven, J.G. Zhang, M. Soilu-Hanninen, H. Hochrein, F. Chionh, K.A. Shipham, B. Emery, A.M. Turnley, S. Petratos, M. Ernst, P.F. Bartlett and T.J. Kilpatrick (2002) LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat. Med. 8 613-619.
27. N.R. Cashman, H.D. Durham, J.K. Blusztajn, K. Oda, T. Tabira, I.T. Shaw, S. Dahrouge and J.P. Antel (1992) Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 194 209-221.
28. M.S. Chen, A.B. Huber, M.E. van der Haar, M. Frank, L. Schnell, A.A. Spillmann, F. Christ and M.E. Schwab (2000) Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403 434-439.
29. B. Ciric, C.L. Howe, M. Paz Soldan, A.E. Warrington, A.J. Bieber, V. Van Keulen, M. Rodriguez and L.R. Pease (2003) Human monoclonal IgM antibody promotes CNS myelin repair independent of Fc function. Brain Pathol. 13 608-616.
30. J.L. Croxford, J.K. Olson and S.D. Miller (2002) Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis. Autoimmun. Rev. 1 251-260.
31. M.C. Dal Canto and H.L. Lipton (1982) Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infections. Am. J. Pathol. 106 20-29.
32. J.B. Daniels, A.M. Pappenheimer and S. Richardson (1952) Observations on encephalomyelitis of mice (DA strain). J. Exp. Med. 96 517-530.
33. M.R. Dawson, J.M. Levine and R. Reynolds (2000) NG2-expressing cells in the central nervous system: Are they oligodendroglial progenitors? J Neurosci. Res. 61 471-479.
34. B.A. DeJong and M.E. Smith (1997) A role for complement in phagocytosis of myelin. Neurochem Res. 22 491-498.
35. K.M. Drescher, P.D. Murray, C.S. David, L.R. Pease and M. Rodriguez (1999) CNS cell populations are protected from virus-induced pathology by distinct arms of the immune system. Brain Pathol. 9 21-31.
36. K.M. Drescher, L.R. Pease and M. Rodriguez (1997) Antiviral immune responses modulate the nature of central nervous system (CNS) disease in a murine model of multiple sclerosis. Immunol. Rev. 159 177-193.
37. C.A. Dyer (1993) Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands. Mol. Neurobiol. 7 1-22.
38. C.A. Dyer and J.A. Benjamins (1988) Antibody to galactocerebroside alters organization of oligodendroglial membrane sheets in culture. J. Neurosci. 8 4307-4318.
39. C.A. Dyer and J. Benjamins J.a. (1989) Organization of oligodendroglial membrane sheets: II. Galctocerebroside: antibody interactions signal changes in cytoskeleton and myelin basic protein. J. Neurosci. Res. 24 212-221.
40. C.A. Dyer and J.A. Benjamins (1990) Glycolipids and transmembrane signaling: Antibodies to galactocerebroside cause an influx of calcium in oligodendrocytes. J. Cell Biol. 111 625-633.
41. C.A. Dyer and J.A. Benjamins (1991) Galactocerebroside and sulfatide independently mediate Ca2+responses in oligodendrocytes. J. Neurosci. Res. 30 699-711.
42. C.A. Dyer and J.M. Matthieu (1994) Antibodies to myelin/oligodendrocyte-specific protein and myelin/oligodendrocyte glycoprotein signal distinct changes in the organization of cultured oligodendroglial membrane sheets. J. Neurochem. 62 777-787.
43. B. Ellezam, J. Bertrand, P. Dergham and L. McKerracher (2003) Vaccination stimulates retinal ganglion cell regeneration in the adult optic nerve. Neurobiol. Dis. 12 1-10.
44. S.S. Ferguson (2003) Receptor tyrosine kinase transactivation: Fine-tuning synaptic transmission. Trends Neurosci. 26 119-122.
45. L. Fiette, C. Aubert, M. Brahic and C.P. Rossi (1993) Theiler's virus infection of beta 2-microglobulin-deficient mice. J. Virol. 67 589-592.
46. N.G. Forger, D. Prevette, O. deLapeyriere, B. de Bovis, S. Wang, P. Bartlett and R.W. Oppenheim (2003) Cardiotrophin-like cytokine/cytokine-like factor 1 is an essential trophic factor for lumbar and facial motoneurons in vivo. J. Neurosci. 23 8854-8858.
47. C.J. Froelich, K. Orth, J. Turbov, P. Seth, R. Gottlieb, B. Babior, G.M. Shah, R.C. Bleackley, V.M. Divit and W. Hanna (1996) New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J. Biol. Chem. 271 29073-29079.
48. E.E. Frost, J.A. Nielsen, T.Q. Le and R.C. Armstrong (2003) PDGF and FGF2 regulate oligodendrocyte progenitor responses to demylination. J. Neurobiol. 54 457-472.
49. C.P. Genain, B. Gannella, S.L. Hauseer and C.S. Raine (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5 170-175.
50. C.P. Genain, M.H. Nguyen, N.L. Letvin, R. Pearl, R.L. Davis, M. Adelman, M.B. Lees, C. Linington and S.L. Hauser (1995) Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest. 96 2966-2974.
51. T. GrandPre, F. Nakamura, T. Vartanian and S.M. Strittmatter (2000) Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403 439-444.
52. T.A. Graubert, J.F. DiPersio, J.H. Russell and T.J. Ley (1997) Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J. Clin. Invest. 100 904-911.
53. S.K. Hanks, L. Ryzhova, N.Y. Shin and J. Brabek (2003) Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front Biosci. 8 D982-D996.
54. T. Harder, P. scheiffele, P. Verkade and K. Simons (1998) Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol. 141 929-942.
55. T. Harder and K. Simons (1997) Caveolae DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr. Opin. Cell Biol. 9 534-542.
56. H. Hering, C.C. Lin and M. Sheng (2003) Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J. Neurosci. 23 3262-3271.
57. D.C. Hoessli, S. Ilangumaran, A. Soltermann, P.J. Robinson, B. Borisch and D. Nasir Ud. (2000) Signaling through sphingolipid microdomains of the plasma membrane: The concept of signaling platforn. Glycoconj J. 17 191-197.
58. K.B. Hoffman, M. Kessler and G. Lynch (1997) Sialic acid residues indirectly modulate the binding properties of AMPA-type glutamate receptors. Brain Res. 753 309-314.
59. R. Hoftberger, F. Aboul-Enein, W. Brueck, C. Lucchinetti, M. Rodriguez, M. Schmidbauer, K. Jellinger and H. Lassmann (2004) Expression of major histocompatibility complex class I molecules on the diferent cell types in multiple sclerosis lesions. Brain Pathol. 14 43-50.
60. C.L. Howe, A.J. Bieber, A.E. Warrington, L.R. Pease and M. Rodriguez (2004) Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. Neurobiol. Dis. 15 120-131.
61. D.W. Huang, L. McKerracher, P.E. Braun and S. David (1999) A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron 24 639-647.
62. S. Hulshof, L. Montagne, C.J. De Groot and P. Van Der Valk (2002) Cellular localization and expression patterns of interleukin-10 interleukin-4, and their receptors in multiple sclerosis lesions. Glia 38 24-35.
63. K. Ikeda, M. Kinoshita, N. Tagaya, T. Shiojima, T. Taga, K. Yasukawa, H. Suzuki and A. Okano (1996) Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease. Brain Res. 726 91-97.
64. I. Jean, C. Allamargot, A. Barthelaix-Pouplard and C. Fressinaud (2002) Axonal lesions and PDGF-enhanced remyelination in the rat corpus callosum after lysolecithin demyelination. Neuroreport 13 627-631.
65. A.J. Johnson, M.K. Jjenga, M.J. Hansen, S.T. Kuhns, L. Chen, M. Rodriguez and L.R. Pease (1999) Prevalent class 1-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J. Virol. 73 3702-3708.
66. A.J. Johnson, J. Upshaw, K.D. Pavelko, M. Rodriguez and L.R. Pease (2001) Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler's virus infection. FASEB J. 15 2760-2762.
67. S.T. Ju, H. Cui, D.J. Panka, R. Ettinger and A. Marshak-Rothstein (1994) Participation of target Fas protein in apoptosis pathway induced by CD4+Th1 and CD8+ cytotoxic T cells. Proc. Natl. Acad. Sci. U. S. A. 91 4185-4189.
68. R.L. Juliano (2002) Signal transduction by cell adhesion receptors and the cytoskeleton: Functions of integrins, cadherins, selectins and immunogobulin-superfamily members. Annu Res. Pharmacol. Toxicol. 42 283-323.
69. K. Kaibuchi, S. Kuroda and M. Amano (1999) Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu. Rev. Biochem. 68 459-486.
70. B.K. Kaspar, J. Llado, N. Sherkat, J.D. Rothstein and F.H. Gage (2003) Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301 839-842.
71. B. Kornek, M.K. Storch, J. Bauer, A. Djamshidian, R. Weissert, E. Wallstroem, A. Stefferl, F. Zimprich, T. Olsson, C. Linington, M. Schmidbauer and H. Lassmann (2001) Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 124 1114-1124.
72. B. Kornek, M.K. Storch, R. Weissert, E. Wallstroem, A. Stefferl, T. Olsson, C. Linington, M. Schmidbauer and H. Lassmann (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active. inactive, and remyelinated lesions. Am. J. Pathol. 157 267-276.
73. E.A. Kramar, J.A. Bernard, C.M. Gall and G. Lynch (2003) Integrins modulate fast excitatory transmission at hippocampal synapses. J. Biol. Chem. 278 10722-10730.
74. S. Lacroix-Desmazes, S.V. Kaveri, L. Mouthon, A. Avouba, E. Malanchere, A. Coutinho and M.D. Kazatchkine (1998) Self-reactive antibodies (natural autoantibodies) in healthy individuals J. Immunol. Methods 216 117-137.
75. D. Lambrechts, E. Storkebaum, M. Morimoto, J. Del-Favero, F. Desmet, S.L. Marklund, S. Wyns, V. Thijs, J. Andersson, L. van Marion, A. Al-Chalabi, S. Bornes, R. Musson, V. Hansen, L. Beckman, R. Adolfsson, H.S. Pall, H. Prats, S. Vemeire, P. Rutgeerts, S. Katayama, T. Awata, N. Leigh, L. Lang-Lazdunski, M. Dewerchin, C. Shaw, L. Moons, R. Vlietinck, K.E. Morrison, W. Robberecht, C. Van Broeckhoven, D. Collen, P.M. Andersen and P. Carmeliet (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 34 383-394.
76. H. Lassmann and H. Wekerle (1998) Experimental models of multiple sclerosis. A. Compston, G. Ebers, H. Lassmann, I. McDonald, B. Matthews, H. Wekerle (Eds) McAlpine's Multiple Sclerosis London: Churchill Livingstone 409-433.
77. M. Levy, C. Aubert and M. Brahic (1992) Theiler's virus replication in brain macrophages cultured in vitro. J. Virol. 66 3188-3193.
78. J. Lieberman (2003) The ABCs of granule-mediated cytotoxicity: New weapons in the arsenal. Nat. Rev. Immunol. 3 361-370.
79. S.T. Lim, R.L. Longley, J.R. Couchman and A. Woods (2003) Direct binding of syndecan-4 cytoplasmic domain to the catalytic domain of protein kinase C alpha (PKC alpha) increases focal adhesion location of PKC alpha. J. Biol. Chem. 278 13795-13802.
80. A. Lin (2003) Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 25 17-24.
81. X. Lin, L.R. Pease and M. Rodriguez (1997) Differential generation of class IH-2D-versus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infection. Eur. J. Immunol. 27 963-970.
82. X. Lin, N.R. Thiemann, L.R. Pease and M. Rodriguez (1995) VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice. Virology 214 91-99.
83. M.D. Lindsley, R. Thiemann and M. Rodriguez (1991) Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus. J. Virol. 65 6612-6620.
84. C. Linington, B. Engelhardt, G. Kapocs and H. Lassman (1992) Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J. Neuroimmunol. 40 219-224.
85. R.A. Linker, M. Maurer, S. Gaupp, R. Martini, B. Holtmann, R. Giess, P. Rieckmann, H. Lassmann, K.V. Toyka, M. Sendtner and R. Gold (2002) CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 8 620-624.
86. H.L. Lipton (1975) Theiler's virus infection in mice: an unusual biphasic disease proces leading to demyelination. Infect. Immunol. 11 1147-1155.
87. H.L. Lipton and M.C. Dal Canto (1976) Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J. Neurol. Sci. 30 201-207.
88. H.L. Lipton and M. Dal Canto (1976) Theiler's virus-induced demyelination: Prevention by immunosuppression. Science 192 62-64.
89. H.L. Lipton and M.C. Dal Canto (1979) Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus. Infect. Immunol. 26 369-374.
90. C. Lucchinetti, W. Bruck, J. Parisi, B. Scheithauer, M. Rodriguez and H. Lassmann (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47 707-717.
91. C.F. Lucchinetti, W. Brueck, M. Rodriguez and H. Lassmann (1998) Multiple sclerosis: Lessons from neuropathology. Semin. Neurol. 18 337-349.
92. S.K. Ludwin and D.A. Bakker (1988) Can oligodendrocytes attached to myelin proliferate? J Neurosci. 8 1239-1244.
93. S.K. Ludwin and E.S. Johnson (1981) Evidence for a "dying-back" gliopathy in demyelinating disease. Ann. Neurol. 9 301-305.
94. R.E. Madrid and H.M. Wisniewski (1977) Axonal degeneration in demyelinating disorders. J. Neurocytol. 6 103-117.
95. G. Mancardi, B. Hart, L. Roccatagliata, H. Brok, D. Giunti, R. Bontrop, L. Massacesi, E. Capello and A. Uccelli (2001) Demyelination and axonal damage in a non-human primate model of multiple sclerosis. J. Neurol. Sci. 184 41-49.
96. J.L. Mason, C. Langaman, P. Morell, K. Suzuki and G.K. Matsushima (2001) Episodic demyelination and subsequent remyelination within the murine central nervous system: Changes in axonal calibre. Neuropathol. Appl. Neurobiol. 27 50-58.
97. G.K. Matsushima and P. Morell (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11 107-116.
98. P.M. Matthews, E. Pioro, S. Narayanan, N. De Stefano, L. Fu, G. Francis, J. Antel, C. Wolfson and D.L. Arnold (1996) Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 119 715-722.
99. W.T. Mayr, S.J. Pittock, R.L. McClelland, N. Jorgensen Nw, J.H. Noseworthy and M. Rodriguez (2003) Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985–2000. Neurology 61 1373-1377.
100. W.I. McDonald and T.A. Sears (1969) Effect of demyelination on conduction in the central nervous system. Nature 221 182-183.
101. R.J. Mead, S.K. Singhrao, J.W. Neal, H. Lassmann and B.P. Morgan (2002) The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J. Immunol. 168 458-465.
102. I. Medana, M.A. Martinic, H. Wekerle and H. Neumann (2001) Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am. J. Pathol. 159 809-815.
103. I.M. Medana, A. Gallimore, A. Oxenius, M.M. Martinic, H. Wekerle and H. Neumann (2000) MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway. Eur. J. Immunol. 30 3623-3633.
104. V. Mehta and M.A. Namboodiri (1995) N-acetylaspartate as an acetyl source in the nervous system. Brain Res. Mol. Brain Res. 31 151-157.
105. S.S. Metkar, B. Wang, M. Aguilar-Santelises, S.M. Raja, L. Uhlin-Hansen, E. Podack, J.A. Trapani and C.J. Froelich (2002) Cytotoxic cell granule-mediated apoptosis: Perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity 16 417-428.
106. I. Mews, M. Bergmann, S. Bunkowski, F. Gullotta and W. Bruck (1998) Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Multiple Sclerosis 4 55-62.
107. D.J. Miller, K.S. Sanborn, J.A. Katzmann and M. Rodriguez (1994) Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J. Neurosci. 14 6230-6238.
108. S.D. Miller, R.J. Clatch, D.C. Pevear, J.L. Trotter and H.L. Lipton (1987) Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins. J. Immunol. 138 3776-3784.
109. S.D. Miller, C.L. Vanderlugt, W.S. Begolka, W. Pao, K.L. Neville, R.L. Yauch and B.S. Kim (1997) Epitope spreading leads to myelin-specific autoimmune responses in SJL mice chronically infected with Theiler's virus. J. Neurovirology. 3 S62-S65.
110. Y. Mitsunaga, B. Ciric, V. Van Keulen, A.E. Warrington, M. PazSoldan, A.J. Bieber, M. Rodriguez and L.R. Pease (2002) Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease. FASEB J. 16 1325-1327.
111. P. Monteyne, J.F. Bureau and M. Brahic (1997) The infection of mouse by Theiler's virus: from genetics to immunology. Immunol. Rev. 159 163-176.
112. M.A. Munoz-Femandez and M. Fresno (1998) The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog. Neurobiol. 56 307-340.
113. P.D. Murray, D.B. McGavern, X. Lin, M.K. Njenga, J. Leibowitz, L.R. Pease and M. Rodriguez (1998) Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J. Neurosci. 18 7306-7314.
114. P.D. Murray, D.B. McGavern, L.R. Pease and M. Rodriguez (2002) Cellular sources and targets of IFN-gamma-mediated protection against viral demyelination and neurological deficits. Eur. J. Immunol. 32 606-615.
115. S. Narayanan, L. Fu, E. Pioro, N. De Stefano, D.L. Collins, G.S. Francis, J.P. Antel, P.M. Matthews and D.L. Arnold (1997) Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions. Ann. Neurol. 41 385-391.
116. H. Neumann (2003) Molecular mechanisms of axonal damage in inflammatory central nervous system diseases. Curr. Opin. Neurol. 16 267-273.
117. H. Neumann, A. Cavalie, D.E. Jenne and H. Wekerle (1995) Induction of MHC class I genes in neurons. Science 269 549-552.
118. H. Neumann, I.M. Medana, J. Bauer and H. Lassmann (2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25 313-319.
119. M.K. Njenga, K. Asakura, S.F. Hunter, P. Wettstein, L.R. Pease and M. Rodriguez (1997) The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J. Virol. 71 8592-8601.
120. M.K. Njenga, K.D. Pavelko, J. Baisch, X. Lin, C. David, J. Leibowitz and M. Rodriguez (1996) Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J. Virol. 70 1729-1737.
121. M.K. Njenga, L.P. Pease, P. Wettstein, T. Mak and M. Rodriguez (1997) Interferon a/b mediates early virus-induced expresson of H-2D and H-2K in the central nervous system. Lab. Invest. 77 71-84.
122. J.H. Noseworthy, C. Lucchinetti, M. Rodriguez and B.G. Weinshenker (2000) Multiple sclerosis. N. Engl. J. Med. 343 938-952.
123. F. Padberg, W. Feneberg, S. Schmidt, M.J. Schwarz, D. Korschenhausen, B.D. Greenberg, T. Nolde, N. Muller, H. Trapmann, N. Konig, H.J. Moller and H. Hampel (1999) CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp 130), but not of interleukin-6 are altered in multiple sclerosis. J. Neuroimmunol. 99 218-223.
124. S.K. Park, D. Solomon and T. Vartanian (2001) Growth factor control of CNS myelination. Dev. Neurosci. 23 327-337.
125. K.D. Pavelko, C.L. Howe, K.M. Drescher, J.D. Gamez, A.J. Johnson, T. Wei, R.M. Ransohoff and M. Rodriguez (2003) Interleukin-6 protects anterior horn neurons from lethal virus-induced injury. J. Neurosci. 23 481-492.
126. C.V. Paya, P.J. Leibson, A.K. Patick and M. Rodriguez (1990) Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha. Int. Immunol. 2 909-913.
127. M.M. Paz Soldan and M. Rodriguez (2002) Heterogeneity of pathogenesis in multiple sclerosis: Implications for promotion of remyelination. J. Infect. Dis. 186 S248-S253.
128. M.M. Paz Soldan, A.E. Warrington, A.J. Bieber, B. Ciric, V. Van Keulen, L.R. Pease and M. Rodriguez (2003) Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol. Cell Neurosci. 22 14-24.
129. C. Pena Rossi, A. McAllister, L. Fiette and M. Brahic (1991) Theiler's virus infection induces a specific cytotoxic T lymphocyte response. Cell Immunol. 138 341-348.
130. M. Penkowa, C. Espejo, E.M. Martinez-Caceres, X. Montalban and J. Hidalgo (2003) Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis. Cell Mol. Life Sci. 60 185-197.
131. M. Penkowa and J. Hidalgo (2003) Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis. J. Neurosci. Res. 72 574-586.
132. H.F. Petereit, R. Pukrop, F. Fazekas, S.U. Bamborschke, S. Ropele, H.W. Kolmel, S. Merkelbach, G. Japp, P.J. Jongen, H.P. Hartung and O.R. Hommes (2003) Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis. J. Neurol. Sci. 206 209-214.
133. A. Petzold, D. Baker, G. Pryce, G. Keir, E.J. Thompson and G. Giovannoni (2003) Quantification of neurodegeneration by measurement of brain-specific proteins. J. Neuroimmunol. 138 45-48.
134. M.J. Pinkoski, M. Hobman, J.A. Heibein, K. Tomaselli, F. Li, P. Seth, C.J. Froelich and R.C. Bleackley (1998) Entry and trafficking of granzyme B in target cells during granzyme B-perforin-mediated apoptosis. Blood 92 1044-1054.
135. S. Pluchino, A. Quattrini, E. Brambilla, A. Gritti, G. Salani, G. Dina, R. Galli, U. Del Carro, S. Amadio, A. Bergami, R. Furlan, G. Comi, A.L. Vescovi and G. Martino (2003) Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422 688-694.
136. N. Prayoonwiwat and M. Rodriguez (1993) The potential for oligodendrocyte proliferation during demyelinating disease. J. Neuropathol. Exp. Neurol. 52 55-63.
137. J.W. Prineas and F. Connell (1979) Remyelination in multiple sclerosis. Ann. Neurol. 5 22-31.
138. J.W. Prineas, E.E. Kwon, P.Z. Goldenberg, A.A. Ilyas, R.H. Quarles, J.A. Benjamins and T.J. Sprinkle (1989) Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Lab. Invest. 61 489-503.
139. L.C. Pullen, S.D. Miller, M.C. Dal Canto and B.S. Kim (1993) Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 23 2287-2293.
140. C.S. Raine and M.B. Bornstein (1970) Experimental allergic encephalomyelitis: A light and electron microscope study of remyelination and "sclerosis" in vitro. J. Neuropathol. Exp. Neurol. 29 552-574.
141. C.S. Raine and A.H. Cross (1989) Axonal dystrophy as a consequence of long-term demyelination. Lab. Invest. 60 714-725.
142. C.S. Raine, F. Mokhtarian and D.E. McFarlin (1984) Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis. Lab. Invest. 51 534-546.
143. R.M. Ransohoff, C.L. Howe and M. Rodriguez (2002) Growth factor treatment of demyelinating disease: at last, a leap into the light. Trends Immunol. 23 512-516.
144. E.J. Redford, R. Kapoor and K.J. Smith (1997) Nitric oxide donors reversibly block axonal conduction: Demyelinated axons are especialy susceptible. Brain 120 2149-2157.
145. J.M. Redwine, M.J. Buchmeier and C.F. Evans (2001) In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection. Am. J. Pathol. 159 1219-1224.
146. A. Rensing-Ehl, U. Malipiero, M. Irmler, J. Tschopp, D. Constam and A. Fontana (1996) Neurons induced to express major histocompatibility complex class I antigen are killed via the perforin and not the Fas (APO-1/CD95) pathway. Eur. J. Immunol. 26 2271-2274.
147. P. Repovic, K. Mi and E.N. Benveniste (2003) Oncostatin M enhances the expression of prostaglandin E2 and cyclooxy genase-2 in astrocytes: Synergy with interleukin-Ibeta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide. Glia 42 433-446.
148. C. Rivera-Quinones, D. McGavern, J.D. Schmelzer, S.F. Hunter, P.A. Low and M. Ródriguez (1998) Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat. Med. 4 187-193.
149. T.M. Rivers and F.F. Schwentker (1935) Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J. Exp. Med. 61 689-702.
150. M. Rodriguez (1985) Virus-induced demyelination in mice: "dying back" of oligodendrocytes. Mayo Clin. Proc. 60 433-438.
151. M. Rodriguez (2003) A function of myelin is to protect axons from subsequent injury: Implications for deficits in multiple sclerosis. Brain 126 751-752.
152. M. Rodriguez and C.S. David (1985) Demyelination induced by Theiler's virus: Influence of the H-2 haplotype. J. Immunol. 135 2145-2148.
153. M. Rodriguez and C.S. David (1995) H-2 Dd transgene suppresses Theiler's virus-induced demyelination in susceptible strains of mice. J. Neurovirol. 1 111-117.
154. M. Rodriguez, A.J. Dunkel, R.L. Thiemann, J. Leibowitz, M. Zijlstra and R. Jaenisch (1993) Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin. J. Immunol. 151 266-276.
155. M. Rodriguez, J. Leibowitz and C.S. David (1986) Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J. Exp. Med. 163 620-631.
156. M. Rodriguez, J.L. Leibowitz and P.W. Lampert (1983) Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 13 426-433.
157. M. Rodriguez and V.A. Lennon (1990) Immunoglobulins promote remyelination in the central nervous system. Ann. Neurol. 27 12-17.
158. M. Rodriguez, V.A. Lennon, E.N. Benveniste and J.E. Merrill (1987) Remyelination by oligodendrocytes stimulated by antiserum to spinalcord. J. Neuropathol. Exp. Neurol. 46 84-95.
159. M. Rodriguez and D.J. Miller (1994) Immune promotion of central nervous system remyelination. Prog. Brain Res. 103 343-355.
160. M. Rodriguez, E. Oleszak and J. Leibowitz (1987) Theiler's murine encephalomyelitis: A model of demyelination and persistence of virus. Crit. Rev. Immunol. 7 325-365.
161. M. Rodriguez, L.J. Zoecklein, C.L. Howe, K.D. Pavelko, J.D. Gamez, S. Nakane and L.M. Papke (2003) Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection. J. Virol. 77 12252-12265.
162. C.P. Rossi, M. Delcroix, L. Huitinga, A. McAllister, R.N. van, E. Classen and M. Brahic (1997) Role of macrophages during Theiler's virus infection. J. Virol. 71 3336-3340.
163. I. Sanchez, L. Hassinger, P.A. Paskevich, H.D. Shine and R.A. Nixon (1996) Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neuro filaments during development independently of myelin formation. J. Neurosci. 16 5095-5105.
164. P. Sarchielli, O. Presciutti, G.P. Pelliccioli, R. Tarducci, G. Gobbi, P. Chiarini, A. Alberti, F. Vicinanza and V. Gallai (1999) Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. Brain 122 513-521.
165. K.H. Schafer, P. Mestres, P. Marz and S. Rose-John (1999) The IL-6/sIL-6R fusion protein hyper-IL-6 promotes neurite outgrowth and neuron survival in cultured enteric neurons. J. Interferon Cytokine Res. 19 527-532.
166. H.J. Schluesener, R.A. Sobel, C. Linington and H.L. Weiner (1987) A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139 4016-4021.
167. M. Schulz, H.J. Schuurman, J. Joergensen, C. Steiner, T. Meerloo, D. Kagi, H. Hengartner, R.M. Zinkernagel, M.H. Schreier, K. Burki, et al. (1995) Acute rejection of vascular heart allografts by perforin-deficient mice. Eur. J. Immunol. 25 474-480.
168. B.M. Segal (2003) Experimental autoimmune encephalomyelitis: Cytokines effector T cells, and antigen-presenting cells in a prototypical Th1-mediated autoimmune disease. Curr. Allergy Asthma Rep. 3 86-93.
169. L. Shi, S. Mai, S. Israels, K. Browne, J.A. Trapani and A.H. Greenberg (1997) Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization. J. Exp. Med. 185 855-866.
170. M. Simons and A. Horowitz (2001) Syndecan-4-mediated signalling. Cell Signal 13 855-862.
171. M.V. Sofroniew, C.L. Howe and W.C. Mobley (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24 1217-1281.
172. I. Sommer and M. Schachner (1981) Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: An immunocytological study in the central nervous system. Dev. Biol. 83 311-327.
173. J. Stegmuller, H. Werner, K.A. Nave and J. Trotter (2003) The proteoglycan NG2 is complexed with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by the PDZ glutamate receptor interaction protein (GRIP) in glial progenitor cells. Implications for glial-neuronal signaling. J. Biol. Chem. 278 3590-3598.
174. J.C. Stevens, M.R. Farlow, M.K. Edwards and P.L. Yu (1986) Magnetic resonance imaging. Clinical correlation in 64 patients with multiple sclerosis. Arch. Neurol. 43 1145-1148.
175. J. Stewart (1992) Immunoglobulins did not arise in evolution to fight infection. Immunol. Today 13 396-399. discussion 399–400
176. M.K. Storch, R. Weissert, A. Steffer, R. Birnbacher, E. Wallstrom, L. Dahlman, C.G. Ostensson, C. Linington, T. Olsson and H. Lassmann (2002) MHC gene related effects on microglia and macrophages in experimental autoimmune encephalomyelitis determine the extent of axonal injury. Brain Pathol. 12 287-299.
177. N. Sun, D. Grzybicki, R.F. Castro, S. Murphy and S. Perlman (1995) Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 213 482-493.
178. W. Sun, H. Funakoshi and T. Nakamura (2002) Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J. Neurosci. 22 6537-6548.
179. R.H. Swanborg (2001) Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity. Immunol. Rev. 184 129-135.
180. A. Thalhammer, L. Everts and M. Hollmann (2002) Inhibition by lectins of glutamate receptor desensitization is determined by the lectin's sugar specificity at kainate but not AMPA receptors. Mol. Cell Neurosci. 21 521-533.
181. M. Theiler (1937) Spontaneous encephalomyelitis of mice, a new virus disease. J. Exp. Med. 65 705-719.
182. A. Thorburn (2004) Death receptor-induced cell killing. Cell Signal 16 139-144.
183. E. Tkachenko and M. Simons (2002) Clustering induces redistribution of syndecan-4 core protein into raft membrane domains. J. Biol. Chem. 277 19946-19951.
184. B.D. Trapp, J. Peterson, R.M. Ransohoff, R. Rudick, S. Mork and L. Bo (1998) Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338 278-285.
185. L. Truyen, J.H. van Waesberghe, M.A. van Walderveen, B.W. van Oosten, C.H. Polman, O.R. Hommes, H.J. Ader and F. Barkhof (1996) Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 47 1469-1476.
186. D. Ure and M. Rodriguez (2000) Extensive injury of descending neurons demonstrated by retrograde labeling in a virus-induced murine model of chronic inflammatory demyelination. J. Neuropathol. Exp. Neurol. 59 664-678.
187. D.R. Ure and M. Rodriguez (2002) Preservation of neurologic function during inflammatory demyelination correlates with axon sparing in a mouse model of multiple sclerosis. Neuroscience 111 399-411.
188. B.G. van Engelen, K.D. Pavelko and M. Rodriguez (1997) Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination. Multiple Sclerosis 3 76-79.
189. J.H. van Waesberghe, W. Kamphorst, C.J. De Groot, M.A. van Walderveen, J.A. Castelijns, R. Ravid, G.J. Lycklama a Nijeholt, P. van der Valk, C.H. Polman, A.J. Thompson and F. Barkhof (1999) Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability. Ann. Neurol. 46 747-754.
190. A. Vincent, O. Lily and J. Palace (1999) Pathogenic autoantibodies to neuronal proteins in neurological disorders. J. Neuroimmunol. 100 169-180.
191. A.E. Warrington, K. Asakura, A.J. Bieber, B. Ciric, V. Van Keulen, S.V. Kaveri, R.A. Kyle, L.R. Pease and M. Rodriguez (2000) Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 97 6820-6825.
192. B.G. Weinshenker, P.C. O'Brien, T.M. Petterson, J.H. Noseworthy, C.F. Lucchinetti, D.W. Dodick, A.A. Pineda, L.N. Stevens and M. Rodriguez (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann. Neurol. 46 878-886.
193. A.J. Windebank, P. Wood, R.P. Bunge and P.J. Dyck (1985) Myelination determines the caliber of dorsal root ganglion neurons in culture. J. Neurosci. 5 1563-1569.
194. Y. Yin, Q. Cui, Y. Li, N. Irwin, D. Fischer, A.R. Harvey and L.I. Benowitz (2003) Macrophage-derived factors stimulate optic nerve regeneration. J. Neurosci. 23 2284-2293.
195. A. Yoneda and J.R. Couchman (2003) Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans. Matrix Biol. 22 25-33.
196. X. Yuan, A.M. Eisen, C.J. McBain and V. Gallo (1998) A role for glutamate and its receptors in the regulation of oligodendrocyte development in cerebellar tissue slices. Development 125 2901-2914.